ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,571.39
      0.08%
      US Tech 100
      19,863.60
      0.09%
      Dow Jones
      39,323.35
      -0.13%
      Brent Oil
      85.535
      -1.12%
      Bitcoin
      56,179.69
      0.60%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Antares Pharma Inc (ATRS)

      7. Antares Pharma Inc (ATRS) News

      ATRS

      Antares Pharma (ATRS)

      Antares Pharma Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ATRS
      DateTimeSourceHeadlineSymbolCompany
      08/01/20177:00AMGlobeNewswire Inc.Antares Pharma to Report Second Quarter 2017 Financial and Operating Results and Host Webcast and Conference CallNASDAQ:ATRSAntares Pharma Inc
      06/26/20178:00AMGlobeNewswire Inc.AMAG Announces U.S. FDA Filing Acceptance of Supplemental New Drug Application for Makena® (hydroxyprogesterone caproate inj...NASDAQ:ATRSAntares Pharma Inc
      06/13/20178:03AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/13/20177:10AMPR Newswire (US)Stock Performance Review on Medical Supplies Industry -- Antares Pharma, Becton, Dickinson, Integra LifeSciences, and WatersNASDAQ:ATRSAntares Pharma Inc
      06/12/20175:44PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:ATRSAntares Pharma Inc
      06/09/20174:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/09/20174:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/09/20174:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/09/20174:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/09/20174:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/09/20174:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/09/20174:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/09/20174:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/09/20174:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/09/20174:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      06/08/201710:22AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      06/07/20174:13PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      06/07/20177:00AMGlobeNewswire Inc.Antares Pharma Announces Debt Financing From Hercules CapitalNASDAQ:ATRSAntares Pharma Inc
      06/01/20177:00AMGlobeNewswire Inc.Antares Pharma to Present at the Jefferies 2017 Healthcare ConferenceNASDAQ:ATRSAntares Pharma Inc
      05/19/20176:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ATRSAntares Pharma Inc
      05/16/20177:00AMGlobeNewswire Inc.Antares Pharma Announces Poster Presentation at the American Urological Association Annual MeetingNASDAQ:ATRSAntares Pharma Inc
      05/09/20175:03PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ATRSAntares Pharma Inc
      05/09/20174:44PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ATRSAntares Pharma Inc
      05/09/20177:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      05/09/20177:00AMGlobeNewswire Inc.Antares Pharma Reports First Quarter 2017 Operating and Financial ResultsNASDAQ:ATRSAntares Pharma Inc
      05/02/20177:00AMGlobeNewswire Inc.Antares Pharma to Report First Quarter 2017 Financial and Operating Results and Host Webcast and Conference CallNASDAQ:ATRSAntares Pharma Inc
      04/27/20174:33PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ATRSAntares Pharma Inc
      04/27/20177:00AMGlobeNewswire Inc.Antares Pharma to Present at the Deutsche Bank Securities, Inc. 42nd Annual Health Care ConferenceNASDAQ:ATRSAntares Pharma Inc
      04/17/20178:00AMGlobeNewswire Inc.AMAG Submits Supplemental New Drug Application to FDA for Makena® (Hydroxyprogesterone Caproate Injection) Auto-Injector for...NASDAQ:ATRSAntares Pharma Inc
      04/12/20176:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
       Showing the most relevant articles for your search:NASDAQ:ATRS